VS
iShares Global Healthcare Index ETF (XHC) and Brompton Global Healthcare Income & Growth ETF (HIG) offer distinct profiles for Canadian ETF investors. A direct comparison shows that XHC focuses its top 3 sector exposures on Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals, while HIG leans towards Healthcare, Finance, and Consumer Non-Cyclicals. When evaluating costs, XHC features a management fee (MER) of 0.63%, compared to 0.75% for HIG. Performance-wise, XHC has returned 6.48% year-to-date with -$47 M in net flows, whereas HIG is at 1.31% with +$10 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
XHC
HIG
| AuM | $543.10 M | $66.93 M |
| Management Fees | 0.63% | 0.75% |
| Exp. ratio | 0.66% | 0.96% |
| Tracking Difference | -0.81% | - |
Historical performance and flows
As of July 27, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | XHC | +3.36% | +13.69% | +6.48% | +19.83% | +20.20% |
HIG | +0.84% | +6.31% | -1.31% | +9.83% | +11.52% | |
| Flows | XHC | +$11 M | -$6 M | -$47 M | -$12 M | -$91 M |
HIG | +$1 M | +$3 M | +$10 M | +$13 M | +$21 M |
XHC vs HIG exposure
Countries
XHC
USA
69.39%
Switzerland
10.35%
Other
20.26%
HIG
USA
78.99%
Other
21.01%
Sectors
XHC
Healthcare
96.86%
HIG
Healthcare
88.74%
Other
11.26%
As of July 27, 2026
Top 10 Holdings
XHC
Eli Lilly & Co.
10.91%
Johnson & Johnson
7.03%
AbbVie, Inc.
5.11%
UnitedHealth Group, Inc.
4.39%
Merck & Co., Inc.
4.11%
AstraZeneca PLC
3.76%
Roche Holding AG
3.75%
Novartis AG
3.72%
Amgen, Inc.
2.53%
Thermo Fisher Scientific, Inc.
2.41%
HIG
Johnson & Johnson
5.83%
Novartis AG
5.59%
Eli Lilly & Co.
5.44%
Cardinal Health, Inc.
5.42%
UnitedHealth Group, Inc.
4.87%
Gilead Sciences, Inc.
4.67%
Vertex Pharmaceuticals, Inc.
4.57%
Bristol Myers Squibb Co.
4.54%
Agilent Technologies, Inc.
4.36%
Merck & Co., Inc.
4.32%
Diversification
XHC
Total weight of top 10 holdings out of 111 total
47.72%
HIG
Total weight of top 10 holdings out of 25 total
49.61%
Characteristics
Compare
XHC
HIG
| Provider | iShares | Brompton Group |
| Management | Passively managed | Actively managed |
| Benchmark | S&P Global 1200 Health Care CAD Hedged Net Total Return Index - CAD | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 1.82% | 8.82% |
| Meets ESG criteria | No | No |
| Inception Date | April 12, 2011 | September 24, 2015 |
Frequently asked questions about XHC and HIG
Which ETF has performed better year to date: XHC or HIG?
As of July 27, 2026, XHC has returned 6.48% year to date, while HIG has returned -1.31%. XHC is ahead on YTD performance.
Which ETF is larger by assets under management: XHC or HIG?
As of July 27, 2026, XHC manages $543.10 M in assets, while HIG manages $66.93 M. XHC is the larger fund by AUM.
How are XHC and HIG managed?
XHC is passively managed by iShares. It tracks the S&P Global 1200 Health Care CAD Hedged Net Total Return Index - CAD benchmark. HIG is actively managed by Brompton Group. It does not track an index.
What sectors do XHC and HIG emphasize?
XHC is most exposed to Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals. HIG is most exposed to Healthcare, Finance, and Consumer Non-Cyclicals.
Which ETF is attracting more investor flows: XHC or HIG?
Year to date, XHC has seen -$47.21 M in net flows, compared with +$9.60 M for HIG. HIG has attracted more net investor money so far.
How do the fees of XHC and HIG compare?
XHC has an expense ratio of 0.66%, while HIG has an expense ratio of 0.96%.
What are the top holdings of XHC and HIG?
XHC's largest holdings include Eli Lilly & Co., Johnson & Johnson, and AbbVie, Inc.. HIG's top holdings include Johnson & Johnson, Novartis AG, and Eli Lilly & Co..
Which ETF is more diversified: XHC or HIG?
XHC holds 110 securities, while HIG holds 25. On holdings count, XHC is the more diversified portfolio.
Recent articles about XHC and HIG
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.